Chandipura Virus: an emerging tropical pathogen

Area of Science:

• Virology
• Public Health
• Molecular Biology

Background:

• Chandipura Virus (CHPV), a Rhabdoviridae family member, causes severe outbreaks in India, primarily affecting children.
• CHPV infection presents with influenza-like symptoms and neurological complications.
• Transmission occurs through vectors like mosquitoes, ticks, and sand flies.

Purpose of the Study:

• To summarize the characteristics, diagnosis, and prevention strategies for Chandipura Virus (CHPV).
• To highlight the lack of specific treatments and the importance of preventive measures against CHPV.
• To evaluate a Vero cell-based vaccine candidate for CHPV prevention.

Main Methods:

• Real-time one-step reverse-transcriptase PCR (RT-PCR) for CHPV diagnosis.
• Evaluation of a Vero cell-based vaccine candidate.
• Review of epidemiological and clinical characteristics of CHPV.

Main Results:

• CHPV possesses a negative-sense RNA genome encoding five proteins, with P and M proteins being critical.
• A Vero cell-based vaccine candidate demonstrated efficacy as a preventive agent.
• Mannitol is used for symptomatic treatment of brain edema.

Conclusions:

• Effective diagnosis of CHPV is achievable through real-time RT-PCR.
• Prevention is the most effective strategy against CHPV, including vector control, hygiene, and awareness.
• Further development of anti-CHPV agents is needed, but current focus should be on preventive measures.